Possibilities of modern biomarkers for assessing the risk of developing ventricular tachyarrhythmias and sudden cardiac death in patients with chronic heart failure
A. Zh. Gasparyan, Н. Б. Шлевков, A. A. Skvortsov
Abstract
Current biomarkers allow diagnosing a wide array of pathological processes and evaluating effects of therapies and prognosis for cardiological patients. This review focuses on a possibility of using N-terminal pro-brain natriuretic peptide (NT-proBNP), soluble suppressor of tumorigenicity 2 (sST2), galectin-3, and other biomarkers in patients with chronic heart failure for evaluating the risk of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
Topics & Concepts
MedicineHeart failureCardiologySudden cardiac deathInternal medicinePathologicalGalectin-3Sudden deathNatriuretic peptideIL-33, ST2, and ILC PathwaysGalectins and Cancer BiologyCardiac Fibrosis and Remodeling